NISA INVESTMENT ADVISORS, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 118 filers reported holding TG THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$420,341
-80.3%
50,280
-41.6%
0.00%
-81.2%
Q2 2023$2,138,227
+133706.4%
86,080
-19.0%
0.02%
+23.1%
Q1 2023$1,598
+78.9%
106,280
+40.7%
0.01%
+85.7%
Q4 2022$893
-98.5%
75,520
+638.9%
0.01%
+600.0%
Q3 2022$59,000
+1080.0%
10,220
+716.9%
0.00%
Q2 2022$5,000
-99.3%
1,251
-98.3%
0.00%
-100.0%
Q1 2022$719,000
+231.3%
75,651
+303.5%
0.01%
+150.0%
Q4 2021$217,000
-75.6%
18,751
-29.8%
0.00%
-60.0%
Q3 2021$889,000
-14.0%
26,717
+0.2%
0.01%
-16.7%
Q2 2021$1,034,000
-18.6%
26,655
+1.1%
0.01%
-25.0%
Q1 2021$1,270,000
-8.1%
26,355
-0.8%
0.01%
-11.1%
Q4 2020$1,382,000
+145.5%
26,570
+26.2%
0.01%
+80.0%
Q3 2020$563,000
+57.7%
21,050
+14.7%
0.01%
+66.7%
Q2 2020$357,000
+97.2%
18,3500.0%0.00%
+50.0%
Q1 2020$181,000
-11.7%
18,350
-0.4%
0.00%0.0%
Q4 2019$205,000
+99.0%
18,4250.0%0.00%
+100.0%
Q3 2019$103,000
-35.2%
18,4250.0%0.00%
-50.0%
Q2 2019$159,000
+7.4%
18,4250.0%0.00%
+100.0%
Q1 2019$148,000
+94.7%
18,4250.0%0.00%0.0%
Q4 2018$76,000
+1420.0%
18,425
+1891.9%
0.00%
Q3 2018$5,000
-58.3%
9250.0%0.00%
Q2 2018$12,000
+71.4%
925
+76.2%
0.00%
Q1 2018$7,000
-30.0%
525
-56.2%
0.00%
Q4 2017$10,000
-16.7%
1,200
+20.0%
0.00%
Q3 2017$12,000
+20.0%
1,0000.0%0.00%
Q2 2017$10,000
+42.9%
1,000
+66.7%
0.00%
Q1 2017$7,0006000.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
RA Capital Management 8,198,337$33,613,0001.96%
GREAT POINT PARTNERS LLC 3,000,000$12,300,0001.56%
BRIDGER MANAGEMENT, LLC 3,791,531$15,545,0001.30%
Avoro Capital Advisors LLC 4,750,000$19,475,0001.16%
Opaleye Management Inc. 550,000$2,255,0000.84%
CREDIT AGRICOLE S A 1,307,428$5,360,0000.30%
Eversept Partners, LP 65,000$266,5000.14%
HIGHLAND CAPITAL MANAGEMENT LP 453,360$1,859,0000.14%
683 Capital Management, LLC 500,000$2,050,0000.12%
Artal Group S.A. 400,000$1,640,0000.06%
View complete list of TG THERAPEUTICS INC shareholders